Antibiotics and Gut Microbiota Among Newborn Infants
NCT02072798 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2014-08-12
Summary
Background Women undergoing Caesarean Section (CS) have an increased risk of postpartum infections compared to women undergoing vaginal delivery. In Denmark the incidence of post-CS infections is 7-10%. The most common infections are endometritis, Urinary tract infections (UTI) and wound infections (WI).
Prophylactic antibiotics are effective in preventing postoperative infections and national guidelines recommend that antibiotics should be administered as a single dose immediately before surgical incision. CS is an exception to this pre-incision administration approach. National guidelines recommend administration of antibiotics after umbilical cord clamping to avoid exposure of the child to antibiotics before birth. Recent studies of antibiotic prophylaxis for CS suggest that prophylactic antibiotics administered before incision compared to after umbilical cord clamping may reduce post-CS infections by up to 50%. Two Cochrane reviews from 2012 criticize these types of studies for lack of data for outcomes on the baby and on late infection in the mother.
At birth, all mammals must rapidly adapt to intake of complex milk nutrients via the gut and simultaneously tolerate the invasion of billions of microbes. This requires rapid maturation of the digestive and immune functions to avoid gut disorders and infections. Full-term, breast-fed infants normally adapt well, but factors such as caesarean birth, high hygiene levels, antibiotics treatment and formula feeding may inhibit immune development both short and long term. Birth by caesarean section in high-hygiene hospital environments, and widespread use of antibiotics, are factors that reduce gut microbiota density and diversity in the newborn for some time after birth. On the other hand, high-hygiene environments and antibiotics are essential tools to combat infections, especially for the weakest newborn infants.
This pilot study will be a feasibility study to the original study, which examines the effect of change in timing of prophylactic antibiotics on the rate of post-CS infections (endometritis, UTI and WI). The pilot study focus on antibiotic and changes in the gut microbiota of newborn infants. The feasibility study will only include pregnant women in Odense with a body mass index below 30, and planned cesarean section.
Conditions
- Surgical Wound Infection
- Infection; Cesarean Section
- Complications; Cesarean Section
Interventions
- DRUG
-
Cefuroxime
iv Cefuroxime 1,5g administered 15-60 minutes before incision versus iv Cefuroxime 1,5g administered after umbilical cord clamping
Sponsors & Collaborators
-
University of Copenhagen
collaborator OTHER -
Aase and Ejnar Danielsens Foundation
collaborator OTHER -
Region of Southern Denmark
collaborator OTHER -
University of Southern Denmark
collaborator OTHER -
Odense University Hospital
lead OTHER
Principal Investigators
-
Nana Hyldig, PhD student · Odense University Hospital, department of Plastic Surgery, University of Southern Denmark, Faculty of Health Sciences, institute of Clinical Research, research unit, department of Gynaecology and Obstetrics
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2014-07-31
- Completion
- 2014-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity
NCT00133029 ·Status: TERMINATED ·Phase: PHASE4
-
Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean Delivery
NCT01194115 ·Status: UNKNOWN ·Phase: NA
-
Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery
NCT03007706 ·Status: UNKNOWN
-
Mothers Experience of Pain Following Elective Cesarean Section. A Qualitative Study.
NCT05933993 ·Status: COMPLETED
-
Timing of Prophylactic Antibiotics for Cesarean Sections
NCT00330278 ·Status: COMPLETED ·Phase: NA
-
Persistent Pain After CS Delivery
NCT01996592 ·Status: COMPLETED
-
Intervention for Postpartum Infections Following Caesarean Section
NCT01891006 ·Status: COMPLETED ·Phase: NA
-
Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
NCT06247852 ·Status: COMPLETED
-
Restoration of the Gut Microbiome After Cesarean Section
NCT06264219 ·Status: RECRUITING ·Phase: PHASE1
-
Antibiotic Prophylaxis for Elective Cesarean Section
NCT02177994 ·Status: COMPLETED ·Phase: PHASE3
-
Natural Microbiota Restoration After C-section Birth
NCT02567071 ·Status: COMPLETED ·Phase: NA
-
EFFECTIVENESS OF PREOPERATIVE VAGINAL CLEANING IN REDUCING POST CAESAREAN INFECTIOUS MORBIDITY
NCT07053995 ·Status: COMPLETED ·Phase: NA
-
Missing Microbes in Infants Born by Cesarean Section
NCT04134819 ·Status: RECRUITING
-
Pain After Cesarean Section - A Danish Multicenter Cohort Study.
NCT06012747 ·Status: COMPLETED
-
Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
NCT03960970 ·Status: UNKNOWN ·Phase: PHASE2
-
PROPHYLACTIC ANTIBIOTICS PRIOR TO CESAREAN SECTION IN OBESE WOMEN
NCT01810354 ·Status: COMPLETED ·Phase: NA
-
no Antibiotics for Elective Cesarean With Low Risk of Infection
NCT02126228 ·Status: COMPLETED
-
Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections
NCT06048692 ·Status: UNKNOWN ·Phase: PHASE3
-
Pain Management After Cesarean Section - A Before-and-After Cohort Study
NCT06813638 ·Status: COMPLETED
-
Trial Comparing the Optimal Timing of Antibiotic Prophylaxis at the Time of Cesarean Delivery
NCT00811603 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section
NCT04009772 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery
NCT01347593 ·Status: COMPLETED ·Phase: PHASE4
-
Mothers' Experience of Category 1 Cesarean Section
NCT05840367 ·Status: RECRUITING
-
Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection
NCT00670020 ·Status: COMPLETED ·Phase: NA
-
The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section
NCT02742948 ·Status: UNKNOWN ·Phase: PHASE2